标题
The mineralocorticoid receptor—an emerging player in metabolic syndrome?
作者
关键词
-
出版物
JOURNAL OF HUMAN HYPERTENSION
Volume 35, Issue 2, Pages 117-123
出版商
Springer Science and Business Media LLC
发表日期
2021-02-01
DOI
10.1038/s41371-020-00467-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Body mass index predicts aldosterone production in hypertensive postmenopausal women
- (2019) Lijun Li et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial (MIRAD trial)
- (2019) Marie L. Johansen et al. DIABETES OBESITY & METABOLISM
- Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test – Variability Between Immunoassay and HPLC-MS/MS
- (2019) Moe Thuzar et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Global Epidemic of the Metabolic Syndrome
- (2018) Mohammad G. Saklayen CURRENT HYPERTENSION REPORTS
- The regulation of aldosterone secretion by leptin
- (2018) Jessica L. Faulkner et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study
- (2018) Gregory L Hundemer et al. Lancet Diabetes & Endocrinology
- Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis
- (2018) Silvia Monticone et al. Lancet Diabetes & Endocrinology
- Mineralocorticoid Antagonism Enhances Brown Adipose Tissue Function In Humans: A Randomized Placebo-controlled Cross-over Study
- (2018) Moe Thuzar et al. DIABETES OBESITY & METABOLISM
- Obesity as a key factor underlying idiopathic hyperaldosteronism
- (2018) Youichi Ohno et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Renin‐Angiotensin‐Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA
- (2018) Joshua J. Joseph et al. Journal of the American Heart Association
- Sex Differences in Mechanisms of Hypertension Associated With Obesity
- (2017) Jessica L. Faulkner et al. HYPERTENSION
- 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
- (2017) Peter Kolkhof et al. JOURNAL OF ENDOCRINOLOGY
- Risk of new-onset diabetes mellitus in primary aldosteronism
- (2017) Vin-Cent Wu et al. JOURNAL OF HYPERTENSION
- Aldosterone in vascular and metabolic dysfunction
- (2016) James M. Luther CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Adipocyte-Specific Mineralocorticoid Receptor Overexpression in Mice Is Associated With Metabolic Syndrome and Vascular Dysfunction: Role of Redox-Sensitive PKG-1 and Rho Kinase
- (2016) Aurelie Nguyen Dinh Cat et al. DIABETES
- MECHANISMS IN ENDOCRINOLOGY: Brown adipose tissue in humans: regulation and metabolic significance
- (2016) Moe Thuzar et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female MiceNovelty and Significance
- (2016) Anne-Cécile Huby et al. HYPERTENSION
- Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant HypertensionNovelty and Significance
- (2016) Tanja Dudenbostel et al. HYPERTENSION
- A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet
- (2016) C Mammi et al. INTERNATIONAL JOURNAL OF OBESITY
- Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry
- (2015) Gregor Hanslik et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 SynthaseNovelty and Significance
- (2015) Riccardo Urbanet et al. HYPERTENSION
- Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism
- (2015) Shigehiro Karashima et al. HYPERTENSION RESEARCH
- Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4‐Year Follow‐Up
- (2015) Alessia Buglioni et al. Journal of the American Heart Association
- Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice
- (2014) Andrea Armani et al. FASEB JOURNAL
- Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet
- (2013) Tsutomu Wada et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance: An Early Contributor to Diabetes-Related Vascular Disease?
- (2013) S. B. Bender et al. DIABETES
- Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects
- (2013) R. Garg et al. DIABETES OBESITY & METABOLISM
- AntioxidantN-Acetylcysteine Protects Pancreatic β-Cells Against Aldosterone-Induced Oxidative Stress and Apoptosis in Femaledb/dbMice and Insulin-Producing MIN6 Cells
- (2013) Hui Min Jin et al. ENDOCRINOLOGY
- Aldosterone Excess Impairs First Phase Insulin Secretion in Primary Aldosteronism
- (2013) Evelyn Fischer et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Primary aldosteronism and essential hypertension: Assessment of cardiovascular risk at diagnosis and after treatment
- (2013) F. Turchi et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Contribution of glucocorticoid–mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction
- (2012) Ayumu Hirata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Ubiquitous Mineralocorticoid Receptor: Clinical Implications
- (2012) Urseline A. Hawkins et al. CURRENT HYPERTENSION REPORTS
- Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult males
- (2012) Alexander W. Krug et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets
- (2011) J. M. Luther et al. DIABETOLOGIA
- Spironolactone Improves Glucose and Lipid Metabolism by Ameliorating Hepatic Steatosis and Inflammation and Suppressing Enhanced Gluconeogenesis Induced by High-Fat and High-Fructose Diet
- (2010) Tsutomu Wada et al. ENDOCRINOLOGY
- Antiadipogenic Effects of the Mineralocorticoid Receptor Antagonist Drospirenone: Potential Implications for the Treatment of Metabolic Syndrome
- (2010) Massimiliano Caprio et al. ENDOCRINOLOGY
- Nonalcoholic Fatty Liver Disease in Primary Aldosteronism: A Pilot Study
- (2009) F. Fallo et al. AMERICAN JOURNAL OF HYPERTENSION
- Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice
- (2009) Ayumu Hirata et al. CARDIOVASCULAR RESEARCH
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Sex-Specific Impact of Aldosterone Receptor Antagonism on Ventricular Remodeling and Gene Expression after Myocardial Infarction
- (2009) Rosemeire M. Kanashiro-Takeuchi et al. CTS-Clinical and Translational Science
- The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses
- (2009) J Hoppmann et al. JOURNAL OF ENDOCRINOLOGY
- Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory Adipokines
- (2008) Christine Guo et al. CIRCULATION
- Body Mass Index Predicts Plasma Aldosterone Concentrations in Overweight-Obese Primary Hypertensive Patients
- (2008) Gian Paolo Rossi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search